The National Cancer Institute offers a grant for developing innovative molecular analysis technologies for cancer research. This funding opportunity solicits exploratory research projects focused on early-stage, highly innovative, or emerging technologies with significant transformative potential for cancer. The grant emphasizes technologies not yet explored in a cancer-relevant context or those requiring substantial modification for proposed cancer applications. The core focus is on molecular analysis technologies demonstrating a high degree of technical innovation, capable of profoundly impacting investigations into cancer’s molecular and cellular foundations. Successful projects aim to accelerate and enhance research across areas such as cancer biology, prevention, diagnosis, treatment, control, epidemiology, and health disparities. All proposed technologies must rely on molecular and/or cellular characterizations of cancer.
Opportunity ID: 206213
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-13-001 |
| Funding Opportunity Title: | Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 25 |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 09, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 20, 2013 |
| Current Closing Date for Applications: | Sep 20, 2013 |
| Archive Date: | Oct 21, 2013 |
| Estimated Total Program Funding: | $5,000,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education City or township governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Independent school districts Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education For profit organizations other than small businesses State governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing exploratory research projects focused on the inception and development of early stage, highly innovative, technologies or emerging technologies with significant transformative potential that has not yet been explored in a cancer-relevant use. An emerging technology is defined (for the purpose of this FOA) as one that has passed the initial developmental stage, but has not yet been evaluated within the context of a cancer-relevant intended use and requires significant modification for the proposed application. The emphasis of this FOA is on molecular analysis technologies with a high degree of technical innovation with the potential to significantly affect and transform investigations exploring the molecular and cellular bases of cancer. If successful, these technologies would accelerate and/or enhance research in the areas of cancer biology, prevention, diagnosis, treatment, control, epidemiology, and/or cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be based on molecular and/or cellular characterizations of cancer. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-001.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00151433 | Jan 20, 2013 | Sep 20, 2013 | View |
Package 1
Mandatory forms
206213 RR_SF424_1_2-1.2.pdf
206213 PerformanceSite_1_4-1.4.pdf
206213 RR_OtherProjectInfo_1_3-1.3.pdf
206213 RR_KeyPersonExpanded_1_2-1.2.pdf
206213 PHS398_CoverPageSupplement_1_4-1.4.pdf
206213 PHS398_ResearchPlan_1_3-1.3.pdf
206213 PHS398_Checklist_1_3-1.3.pdf
Optional forms
206213 RR_SubawardBudget30-1.2.pdf
206213 PHS398_ModularBudget_1_2-1.2.pdf
206213 RR_Budget-1.1.pdf
206213 PHS_CoverLetter_1_2-1.2.pdf